Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma
- PMID: 11028656
- DOI: 10.1034/j.1399-3003.2000.016003432.x
Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma
Abstract
There is a subset of patients with bronchial asthma who are susceptible to disease exacerbation upon receiving aspirin and other nonsteroidal anti-inflammatory drugs. This is a clinical syndrome, called aspirin-induced asthma (AIA), associated with alterations in arachidonate metabolism and cysteinyl-leukotriene overproduction. The natural history and clinical characteristics of this type of asthma were studied. Sixteen clinical centres in 10 European countries provided standardized information to the specially developed patient-oriented database regarding: medical history, physical examination, diagnosis, and treatment. Diagnosis of AIA was based on a typical history, confirmed by positive aspirin provocation tests, carried out in 91% of the patients. A total of 500 patients were enrolled in the study. AIA developed according to a pattern, characterized by a sequence of symptoms. First, persistent rhinitis, appearing at a mean age of 29.7+/-12.5 yrs, then asthma, aspirin intolerance and nasal polyposis appear. The clinical presentation in different European countries was remarkably similar. In females, who outnumbered males by 2.3:1, the onset of symptoms occurred significantly earlier and the disease was more progressive and severe than in males. Atopy, present in approximately a third of patients, led to earlier manifestation of rhinitis and asthma, but not of aspirin intolerance or nasal polyposis. A family history of aspirin intolerance, recorded in 6% of patients, had a less evident effect on the course of the disease than sex or atopy. Fifty one per cent of patients, in addition to inhaled steroids, required chronic systemic corticosteroid therapy at a mean dose of 8 mg prednisone x day(-1). Surprisingly, 15% of patients were unaware of intolerance to aspirin and learnt about it only after having provocation tests performed. All over Europe, aspirin-induced asthma develops in a similar characteristic way. Its course is influenced by sex and the presence of atopy. In half of the patients, asthma is severe, and steroid-dependent. The uniform natural history of aspirin-induced asthma might suggest a common underlying principle.
Similar articles
-
Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.Acta Otorhinolaryngol Belg. 1995;49(3):235-50. Acta Otorhinolaryngol Belg. 1995. PMID: 7484142 Review.
-
Diagnosis, prevention and treatment of aspirin-induced asthma and rhinitis.Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):1-11. doi: 10.2174/1568010023345011. Curr Drug Targets Inflamm Allergy. 2002. PMID: 14561202 Review.
-
Analgesics and asthma.Am J Ther. 2002 May-Jun;9(3):233-43. doi: 10.1097/00045391-200205000-00009. Am J Ther. 2002. PMID: 11941383 Review.
-
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma.Eur Respir J. 2000 May;15(5):863-9. doi: 10.1034/j.1399-3003.2000.15e09.x. Eur Respir J. 2000. PMID: 10853850 Clinical Trial.
-
Aspirin-induced rhinitis and asthma.Curr Opin Allergy Clin Immunol. 2001 Feb;1(1):27-33. doi: 10.1097/01.all.0000010981.95396.58. Curr Opin Allergy Clin Immunol. 2001. PMID: 11964666 Review.
Cited by
-
[Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].HNO. 2024 Feb 26. doi: 10.1007/s00106-024-01431-0. Online ahead of print. HNO. 2024. PMID: 38409556 Review. German.
-
Polyps' Extension and Recurrence in Different Endotypes of Chronic Rhinosinusitis: A Series of 449 Consecutive Patients.J Clin Med. 2024 Feb 16;13(4):1125. doi: 10.3390/jcm13041125. J Clin Med. 2024. PMID: 38398437 Free PMC article.
-
Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions.J Allergy Clin Immunol Glob. 2024 Jan 9;3(2):100205. doi: 10.1016/j.jacig.2024.100205. eCollection 2024 May. J Allergy Clin Immunol Glob. 2024. PMID: 38317805 Free PMC article.
-
Development of a mobile app for the evaluation of patients with chronic rhinosinusitis.Braz J Otorhinolaryngol. 2023 Dec 14;90(2):101375. doi: 10.1016/j.bjorl.2023.101375. Online ahead of print. Braz J Otorhinolaryngol. 2023. PMID: 38237485 Free PMC article.
-
Risk factors of NSAID-exacerbated respiratory disease: A population-based study.Clin Transl Allergy. 2023 Aug;13(8):e12296. doi: 10.1002/clt2.12296. Clin Transl Allergy. 2023. PMID: 37632242 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical